Phase II trial of capecitabine and rHu-interferon-alpha-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity Article

Industry Collaboration International Collaboration

cited authors

  • Segota, Ena; Mekhail, Tarek; Olencki, Thomas; Hutson, Thomas E.; Dreicer, Robert; Wacker, Brenda; Osterwalder, Bruno; Elson, Paul; Zhou, Ming; Bukowski, Ronald M.

authors

Publication Date

  • January 1, 2007

webpage

published in

category

keywords

  • cancer
  • capecitabine
  • carcinoma
  • interferon
  • kidney
  • renal

start page

  • 46

end page

  • 52

volume

  • 25

issue

  • 1